News Conference News ACC 2023 Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT Yael L. Maxwell March 07, 2023
News Conference News ACC 2018 Googling of Cardiac Symptoms Tracks With Hospital Admissions for Coronary Disease Yael L. Maxwell March 09, 2018
News Conference News ACC 2014 ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation Yael L. Maxwell April 03, 2014
Presentation ACC 2014 The Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS) Presenter: M. Valgimigli March 31, 2014
News Conference News ACC 2014 ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates Yael L. Maxwell March 31, 2014
News Conference News ACC 2013 ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting L.A. McKeown March 14, 2013
News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012
News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
News Conference News ACC 2012 Adjunctive Cilostazol Noninferior to Double-Dose Clopidogrel in All-Comer PCI Trial L.A. McKeown March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012